[Dynamics of clinical, immunologic and cytologic indices in the treatment of Sjögren's disease with the preparation ENKAD].
Makarova
O V
OV
Pozharitskaia
M M
MM
Kop'eva
T N
TN
Fuks
B B
BB
Shabanova
M E
ME
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D002908:Chronic Disease; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D009843:Oligoribonucleotides; D012265:Ribonucleotides / Q000627:therapeutic use*; D012463:Saliva / Q000166:cytology / Q000187:drug effects; D012859:Sjogren's Syndrome / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology
D000276:Adjuvants, Immunologic; D000894:Anti-Inflammatory Agents, Non-Steroidal; D009843:Oligoribonucleotides; D012265:Ribonucleotides; C031373:ENKAD
Dinamika klinicheskikh, immunologicheskikh i tsitologicheskikh pokazateleĭ pri lechenii bolezni Shegrena preparatom ENKAD.